Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry].
van Zeijl MCT, van den Eertwegh AJM, Wouters MWJM, Jochems A, Schouwenburg MG, Haanen JBAG, Aarts MJ, van den Berkmortel FWPJ, de Groot JWB, Hospers GAP, Kapiteijn E, Koornstra RH, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, van der Veldt AAM, Vreugdenhil G, van der Hoeven KJM. van Zeijl MCT, et al. Among authors: suijkerbuijk kpm. Ned Tijdschr Geneeskd. 2018 Jun 15;162:D2420. Ned Tijdschr Geneeskd. 2018. PMID: 30040270 Dutch.
Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition.
van Eijs MJM, Verheijden RJ, van der Wees SA, Nierkens S, van Lindert ASR, Suijkerbuijk KPM, van Wijk F; UNICIT consortium. van Eijs MJM, et al. Among authors: suijkerbuijk kpm. Cancer Immunol Immunother. 2023 Dec;72(12):4049-4064. doi: 10.1007/s00262-023-03541-0. Epub 2023 Oct 4. Cancer Immunol Immunother. 2023. PMID: 37794264 Free PMC article.
Added diagnostic value of routinely measured hematology variables in diagnosing immune checkpoint inhibitor mediated toxicity in the emergency department.
Niemantsverdriet MSA, Vrijsen BEL, Visser 't Hooft T, Suijkerbuijk KPM, van Solinge WW, Ten Berg MJ, Haitjema S. Niemantsverdriet MSA, et al. Among authors: suijkerbuijk kpm. Cancer Med. 2023 Jun;12(11):12462-12469. doi: 10.1002/cam4.5956. Epub 2023 Apr 19. Cancer Med. 2023. PMID: 37076947 Free PMC article.
Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publication.
Sharouni ME, Lo SN, Varey AH, Elias SG, Witkamp AJ, Sigurdsson V, Suijkerbuijk KP, van Diest PJ, van Gils CH, Blokx WA, Scolyer RA, Thompson JF. Sharouni ME, et al. Future Oncol. 2023 Jan;19(2):97-102. doi: 10.2217/fon-2022-0525. Epub 2023 Feb 10. Future Oncol. 2023. PMID: 36762595 Free article. Review.
Physical activity and checkpoint inhibition: association with toxicity and survival.
Verheijden RJ, Cabané Ballester A, Smit KC, van Eijs MJM, Bruijnen CP, van Lindert ASR, Suijkerbuijk KPM, May AM. Verheijden RJ, et al. Among authors: suijkerbuijk kpm. J Natl Cancer Inst. 2024 Apr 5;116(4):573-579. doi: 10.1093/jnci/djad245. J Natl Cancer Inst. 2024. PMID: 38001030 Free PMC article.
Living in the twilight zone: a qualitative study on the experiences of patients with advanced cancer obtaining long-term response to immunotherapy or targeted therapy.
Zwanenburg LC, Suijkerbuijk KPM, van Dongen SI, Koldenhof JJ, van Roozendaal AS, van der Lee ML, Schellekens MPJ. Zwanenburg LC, et al. Among authors: suijkerbuijk kpm. J Cancer Surviv. 2024 Jun;18(3):750-760. doi: 10.1007/s11764-022-01306-9. Epub 2022 Dec 10. J Cancer Surviv. 2024. PMID: 36495465 Free PMC article.
Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands.
Franken MG, Leeneman B, Jochems A, Schouwenburg MG, Aarts MJB, van Akkooi ACJ, van den Berkmortel FWPJ, van den Eertwegh AJM, de Groot JWB, van der Hoeven KJM, Hospers GAP, Kapiteijn E, Koornstra R, Kruit WHJ, Louwman MWJ, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, Vreugdenhil G, Wouters MWJM, van Zeijl M, Haanen JBAG, Uyl-de Groot CA. Franken MG, et al. Among authors: suijkerbuijk kpm. Anticancer Drugs. 2018 Jul;29(6):579-588. doi: 10.1097/CAD.0000000000000628. Anticancer Drugs. 2018. PMID: 29634490
125 results